Filing Details

Accession Number:
0001562180-15-000223
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-27 11:22:26
Reporting Period:
2015-03-25
Filing Date:
2015-03-27
Accepted Time:
2015-03-27 11:22:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612859 Stephen Kanes C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-25 5,400 $51.49 46,948 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $51.38 USD to $51.645 USD. The price reported above reflects the weighted average sale price.